Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
The PFAS Accountability Act creates a federal legal pathway for Americans exposed to per- and polyfluoroalkyl substances (PFAS)—chemicals widely used in manufacturing that have been detected in the blood of millions of Americans and linked to serious health problems including cancer and reproductive harm. The bill amends the Toxic Substances Control Act to allow individuals or groups who have been significantly exposed to PFAS to sue manufacturers and users of these chemicals in federal court and seek compensation for medical monitoring costs. Courts can order companies to pay for ongoing medical exams and independent research into PFAS health effects, shifting these costs from exposed individuals to responsible companies. The legislation applies to anyone demonstrably exposed to PFAS for at least one year or who has PFAS detected in their blood, with the burden on manufacturers to prove exposure didn't occur if they wish to contest claims. The bill does not eliminate state-level lawsuits and is designed to incentivize industry investment in PFAS safety research while holding manufacturers accountable for widespread contamination.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.